Page last updated: 2024-08-18

dimethyldioctadecylammonium and Malaria

dimethyldioctadecylammonium has been researched along with Malaria in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aagaard, C; Agger, EM; Andersen, P; Brahimi, K; Christensen, D; Follmann, F; Hansen, J; Kirschning, C; Lang, R; Rosenkrands, I; Theisen, M; Vandahl, BS; Werninghaus, K1
Barnwell, JW; Desowitz, RS1

Other Studies

2 other study(ies) available for dimethyldioctadecylammonium and Malaria

ArticleYear
Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements.
    PloS one, 2008, Sep-08, Volume: 3, Issue:9

    Topics: Adjuvants, Immunologic; Animals; Cations; Chlamydia trachomatis; Female; Glycolipids; Humans; Liposomes; Malaria; Mice; Mice, Inbred C57BL; Mycobacterium; Mycobacterium tuberculosis; Plasmodium yoelii; Quaternary Ammonium Compounds; T-Lymphocytes; Vaccines

2008
Effect of selenium and dimethyl dioctadecyl ammonium bromide on the vaccine-induced immunity of Swiss-Webster mice against malaria (Plasmodium berghei).
    Infection and immunity, 1980, Volume: 27, Issue:1

    Topics: Animals; Female; Malaria; Mice; Plasmodium berghei; Quaternary Ammonium Compounds; Selenium

1980